EGFR and breast carcinoma: Additional reports have characterized a relationship between IGF-1R and EGFR signaling in aggressive, drug-resistant breast cancer cells and have speculated that IGF-1R signaling plays a role in the development of gefitinib resistant EGFR tumors [31].